The DNA mutations that accumulate over time as women age are not the sole contributor to the higher frequency of breast cancer in…

European health regulators recommended Roche’s breast cancer drug Perjeta for approval on Friday, cementing the company’s hopes that the drug will become the standard of care for an…

Women who have higher levels of nutrients commonly found in vegetables may have a lower risk of developing breast cancer, say researchers at Brigham & Women’s…

A randomized trial found bevacizumab (Avastin) failed to improve outcomes in combination with chemotherapy in early triple-negative breast cancer, adding to the string of failures for the drug.

Invasive…

Vitamin D levels may be part of the reason some women saw a benefit from adding a bone drug to standard breast cancer chemotherapy regimens, a researcher said.

Postmenopausal women…

One of the most frustrating truths about cancer is that even when a treatment works, it often doesn’t work for long because cancer cells find ways to…

Current screening tests may miss as many as 1 in 50 women with breast cancer who would benefit from treatment with highly effective breast cancer drugs.

At issue is…

While pink is usually the color most associated with breast cancer advocacy, women may want to think red and orange if they’re looking to lower…

More patients can benefit from highly effective breast cancer drugs that are already available, according to DNA sequencing studies by researchers at Washington University School of Medicine in St.…

Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this…

Swiss pharma group Roche’s drug Perjeta significantly extended the lives of women with an aggressive and incurable form of breast cancer compared to a placebo, according to new data from…

A new review of existing evidence suggests that using magnetic resonance imaging to “stage” a woman’s breast cancer before surgery might do more harm than good.

MRI produces a…

Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen)…

African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive…

Most patients whose breast cancer has spread to their lymph nodes have most of the lymph nodes in their armpit area removed after chemotherapy to…

About 70 percent of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer…

Controversial U.S. guidelines for mammography issued in 2009, calling for screening every two years rather than annually for women over 50 years old, can result in breast cancers being…

So a study of numbers and percentages decides that routine mammograms are probably not financially worth it? What about a study of lives saved, hope restored and loved ones still…

Epithelial cells are homebodies – they like to attach to things and becoming detached initiates a form of cell suicide known as anoikis (literally “homeless” in Latin). But in order for…

Is there a link between the risk of breast cancer and the working environment? A study published in BioMed Central’s open access journal Environmental Health provides further evidence on…

Straightforward imaging with an infrared, thermal, camera for detecting breast cancer early without the discomfort or inconvenience of mammography or biomolecular tests, according to a study to be published in the International Journal…

A new three-dimensional (3-D) digital mammography technique has the potential to significantly improve the accuracy of breast cancer screening, according to a study published in Radiology.

Two-dimensional (2-D) x-ray mammography,…

The World Health Organisation (WHO) has predicted that by 2020 the number of breast cancer cases will jump to an alarming figure and one in every eight women would run…

As many are aware, when breast cancer is detected early, it can be successfully treated in over 90 percent of cases. Women without health insurance are typically screened for breast cancer…

Roche, the world’s biggest maker of cancer drugs, said U.S. health regulators granted a priority review to its experimental breast cancer drug TDM-1, expediting the review process for…